We have advised Shore Capital (Nominated Adviser, Joint Broker and Joint Bookrunner) and Stifel (Joint Broker & Joint Bookrunner) on a $354 million (£265.5 million) placing and retail offer for Kape Technologies plc, a leading B2C privacy-first digital security software provider.
The capital raise was structured as an accelerated bookbuild placing, and was supported by new and existing institutional shareholders, including a number of blue-chip institutional investors from the UK, USA, Israel and Asia. The proceeds of the raise will be used to fund the upfront consideration for the…
We have advised leading data-driven underwriting and risk analytics business Envelop Risk on its Series B financing of $130 million led by SoftBank Vision Fund 2. The investment is intended to support the business in expanding its proprietary machine-learning and data-driven underwriting activity in London and Bermuda, with hopes to accelerate growth into new markets globally and beyond cyber (re)insurance.
Founded in 2016 with a vision of transforming how the insurance industry quantifies and manages risk, Envelop Risk underwrites bespoke reinsurance for global insurance firms,…
Israel has long been one of the world's leading exporters of online gambling and casino companies, a sector that has boomed during the pandemic.
The convergence of multiple trends in the online gaming industry (the acceleration of games as social networks and content platforms, and a push toward cross-media integration, cloud gaming and subscription services) is underpinning buoyant times for investment and M&A activity in the sector. Indeed, the last few years have seen a huge acceleration of growth and increased deal activity, both from existing video games industry players and new…
Cambridge, UK, 23 Sept 2021: o2h co-work labs, a business unit of o2h Group, are absolutely delighted to launch the first ever influencer biotech bootcamp covering representatives from the quintet influencer community that are the creative forces driving biotech. The event is going to be held at the newly renovated the old Mill house at the Mill SciTech Park, where o2h co-work labs is building a community of creators covering life-science, technology and green innovation.
Looking far beyond the ‘start-up’ skills the bootcamp endeavours to bring together a dozen influencers covering the…
Cambridge, UK, 27 September 2021: Chesterford Research Park is delighted to announce the expansion of an existing occupier, SuperDielectrics, into new laboratory and write up space within the Emmanuel Building. Superdielectrics first moved to Chesterford Research Park in February this year, taking a suite in the multi-occupancy Science Village building. Due to the accelerated development of its proprietary technology, the organisation required the ability to scale-up swiftly and the newly completed Emmanuel Building at the Park provided the ideal opportunity at the right time.The…
On September 23, key stakeholders attended an event to celebrate the launch of The Lucy Cavendish Life Sciences Community. The event proved to be a useful forum for members of the community to meet and network and an opportunity to find out more about future plans. The Community is a collaboration of local Cambridge life-science businesses and provides essential funds for STEMM students during their study. It aims to build mutually beneficial, long-term relationships between local businesses, STEMM students, the College and the wider university. During the event, Madeleine Atkins,…
AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays.Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a target. This target can be an organic molecule, free or carried in cells or tissues, or inorganic components, such as metal ions. Aptamers have generated significant interest as promising tools, that compete with monoclonal antibodies, for…
Cambridge, UK, 22 September 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced that the Company has moved to larger, custom designed laboratory and office premises at Granta Park, Cambridge, UK. The new headquarters will allow the Company to significantly expand its range of services and cell lines.
The 12,000 sq. ft (1,145 m2) facility more than doubles the Company’s laboratory space and has been specifically designed to support the addition of Good Laboratory Practice (GLP) compliant cardiac safety services…
SysMIC is an online course in coding, modelling & data analysis for bioscience researchers.
The next course will start on Monday 1st November 2021
Participants will become confident in using the Python, R and MATLAB platforms, developing interdisciplinary skills that will make them more effective researchers with the confidence to develop and apply computational techniques in modelling and data analysis to their own work.
Our materials were designed by bioscientists, for bioscientists and are focused on biological applications and practical approaches that let participants develop…
San Francisco – Sept. 20, 2021 – Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed capital from other strategic and financial investors, including the Ireland Strategic Investment Fund (ISIF). The fund will support early-stage companies that are pioneering breakthroughs in life science tools, clinical…